Idenix Pharmaceuticals Inc Sample Contracts

EXHIBIT 10.7 CONSULTING AGREEMENT
Consulting Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • Massachusetts
AutoNDA by SimpleDocs
EXHIBIT 1.1 FORM OF UNDERWRITING AGREEMENT IDENIX PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENT
Underwriting Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
INTRODUCTION
License Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
WITNESSETH:
Settlement Agreement • June 1st, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
BY AND AMONG
Stock Purchase Agreement • March 17th, 2005 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
April 24, 2001
Stockholders' Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • New York
W I T N E S S E T H
Lease • April 12th, 2002 • Novirio Pharmaceuticals LTD
IDENIX PHARMACEUTICALS, INC. 22,000,000 Shares of Common Stock Underwriting Agreement
Idenix Pharmaceuticals Inc • August 3rd, 2012 • Pharmaceutical preparations • New York
BETWEEN
License Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
RECITALS
Consulting Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • New York
RECITALS:
Master Services Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.5 March 18, 2002 CONFIDENTIAL Mr. John Dunphy 24 Marion Lane Scotch Plains, New Jersey 07076 Dear Mr. Dunphy: On behalf of Novirio Pharmaceuticals, Inc. ("Novirio"), I am pleased to offer you the position of Chief Financial Officer. In this...
Novirio Pharmaceuticals LTD • April 12th, 2002

On behalf of Novirio Pharmaceuticals, Inc. ("Novirio"), I am pleased to offer you the position of Chief Financial Officer. In this position, you will report directly to Novirio's Chief Executive Officer. The terms of employment set forth below are intended to reflect our prior discussions.

EXHIBIT 10.30 CONCURRENT PRIVATE PLACEMENT STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • June 1st, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT
Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.31 LICENSE AGREEMENT
License Agreement • June 1st, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Alabama
AutoNDA by SimpleDocs
AGREEMENT AND PLAN OF MERGER among IDENIX PHARMACEUTICALS, INC., MERCK & CO., INC. and IMPERIAL BLUE CORPORATION Dated as of June 8, 2014
Agreement and Plan of Merger • June 9th, 2014 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

AGREEMENT AND PLAN OF MERGER (hereinafter called this “Agreement”), dated as of June 8, 2014, by and among Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Merck & Co., Inc., a New Jersey corporation (“Parent”), and Imperial Blue Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub,” with the Company and Merger Sub sometimes being hereinafter collectively referred to as the “Constituent Corporations”).

CO-OPERATIVE
Agreement • May 20th, 2002 • Novirio Pharmaceuticals LTD • Pharmaceutical preparations
FROM
Lease • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
IDENIX PHARMACEUTICALS, INC. 9,393,416 Shares of Common Stock Underwriting Agreement
Idenix Pharmaceuticals Inc • November 16th, 2011 • Pharmaceutical preparations • New York

The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by J.P. Morgan Securities LLC (the “Underwriter”), of common stock, $0.001 par value, of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.

RECITALS
Stock Restriction Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • Massachusetts
RECITALS:
Idenix Pharmaceuticals Inc • August 8th, 2006 • Pharmaceutical preparations
BY AND AMONG
License and Commercialization Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
LEASE
Lease • September 28th, 2012 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 25th day of September, 2012 (the “Execution Date”), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord”), and IDENIX PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!